The efficacy of CI in MYH9-related deafness is made even more uncertain in view of the discordant results obtained in non-syndromic deafness DFNA17: members of both the reported DNFA17 pedigrees received CIs, with good outcomes in one family and very poor results in the other one [16,18]. The gene discussed is MYH9; the disease is deafness.